Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Early Use of Botulinum Toxin in Spasticity Post Stroke. (EUBoSS)

This study has been completed.
Sponsor:
Collaborators:
Keele University
Stroke Research Network
Information provided by (Responsible Party):
Cameron Lindsay, Sandwell & West Birmingham Hospitals NHS Trust
ClinicalTrials.gov Identifier:
NCT01882556
First received: June 18, 2013
Last updated: November 17, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)